3. Harman RJ, Carlson K, Gaynor J, et al. A prospective, randomized,
masked, and placebo-controlled efficacy study of intraarticular allogeneic adipose
stem cells for the treatment of osteoarthritis in dogs. Front Vet Sci. 2016; 3:81.
doi: 10.3389/fvets.2016.00081.
4. Ichim T, Harman R, Ming W, et al. Autologous stromal vascular fraction
cells: A tool for facilitating tolerance in rheumatic disease. Cell Imm. 2010; 264:
7-17.
5. Ichim T, Solano F, Lara F, Paris E, Ugalde F, Rodriguez J, Minev B,
Bogin V, Ramos F, Woods E, Murphy M, Patel A, Harman R, Riordan N.
Feasibility of combination allogeneic stem cell therapy for spinal cord injury: a
case report. Int Arch Med, 3:30, 2010.
6. Riordan N, Ichim T, Harman R et al. Non-expanded adipose stromal
vascular fraction cell therapy for multiple sclerosis. Journal of Translational
Medicine, 7:29, 24 April, 2009.
7. Rodriguez J, Murphy M, Madrigal M, March K, Minev B, Harman R,
Chen C, Berrocal R, Marleau A, Riordan N. Autologous stromal vascular fraction
therapy for rheumatoid arthritis: rationale and clinical safety. Int Arch Med, 5:5,
2012.
8. Wood J, Chung D, Park S, et al. Periocular and intra-articular injection of
canine adipose-derived mesenchymal stem cells: An in vivo imaging and
migration study. Journal of ocular pharmacology and therapeutics: the official
journal of the Association for Ocular Pharmacology and Therapeutics. 2011;
28(3): 307–17.
9. Arzi B, Mills-Ko E, Verstraete FJM, et al. Therapeutic efficacy of fresh,
Autologous Mesenchymal stem cells for severe refractory Gingivostomatitis in
cats. 2015; 5(1).
10. Pérez-Merino E, Usón-Casaús J, Duque-Carrasco J, et al. Safety and
efficacy of allogeneic adipose tissue-derived mesenchymal stem cells for
treatment of dogs with inflammatory bowel disease: Endoscopic and histological
outcomes. Veterinary journal (London, England : 1997). 2015; 206(3): 391-7.
